title: Continuous infusion intravenous immunoglobulin is associated with a reduced incidence of infection and achieves higher serum immunoglobulin G levels than intermittent infusion following bone marrow transplantation.
authors.affiliation: Bone Marrow Transplantation Program, Lombardi Cancer Research Center, Georgetown University Hospital, Washington, DC 20007.
authors.forename: T R
authors.initials: TR
authors.lastname: Spitzer
authors.forename: M
authors.initials: M
authors.lastname: Cottler-Fox
authors.forename: P
authors.initials: P
authors.lastname: Sullivan
authors.forename: M
authors.initials: M
authors.lastname: Lynch
authors.forename: M C
authors.initials: MC
authors.lastname: Tefft
authors.forename: L W
authors.initials: LW
authors.lastname: Pickle
authors.forename: E
authors.initials: E
authors.lastname: Cirenza
authors.forename: R
authors.initials: R
authors.lastname: Cahill
authors.forename: H J
authors.initials: HJ
authors.lastname: Deeg
authors.forename: R
authors.initials: R
authors.lastname: Sacher
mesh_terms: D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects* / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000097:blood*; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D015994:Incidence; D017053:Infection Control / Q000379:methods*; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous